Cellectar Biosciences, Inc. Related Party Transaction, Amounts of Transaction
Cellectar Biosciences, Inc. (CLRB) reported Related Party Transaction, Amounts of Transaction of $187.50 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2015-05-20.
Discontinued › Notes
us-gaap:RelatedPartyTransactionAmountsOfTransaction · last filed 2015-05-20
- Cellectar Biosciences, Inc. related party transaction, amounts of transaction for the quarter ending 2013-12-31 was $125.00K.
- Cellectar Biosciences, Inc. related party transaction, amounts of transaction for the quarter ending 2013-09-30 was $0.00, a 100.00% decline year-over-year.
- Cellectar Biosciences, Inc. related party transaction, amounts of transaction for the quarter ending 2013-06-30 was $62.50K, a 0.00% change year-over-year.
- Cellectar Biosciences, Inc. related party transaction, amounts of transaction for the quarter ending 2012-09-30 was $62.50K, a 0.00% change year-over-year.
- Cellectar Biosciences, Inc. related party transaction, amounts of transaction for fiscal 2013 was $187.50K.
| Period end | Related Party Transaction, Amounts of Transaction 3 month | Related Party Transaction, Amounts of Transaction 6 month | Related Party Transaction, Amounts of Transaction 6 month as first filed | Related Party Transaction, Amounts of Transaction 9 month | Related Party Transaction, Amounts of Transaction 12 month |
|---|---|---|---|---|---|
| 2013-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-20 | $125.00K derived: sum of 2 quarters · filed 2015-05-20 | $187.50K derived: sum of 3 quarters · filed 2015-05-20 | $187.50K 10-K · filed 2015-05-20 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-20 | $62.50K derived: sum of 2 quarters · filed 2015-05-20 | $62.50K 10-Q · filed 2015-05-20 | ||
| 2013-06-30 | $62.50K 10-Q · filed 2013-08-12 | $62.50K 10-Q · filed 2014-08-04 | $125.00K 10-Q · filed 2013-08-12 | ||
| 2012-09-30 | $62.50K 10-Q · filed 2012-11-06 | $125.00K derived: sum of 2 quarters · filed 2012-11-06 | $206.50K 10-Q · filed 2012-11-06 | ||
| 2012-06-30 | $62.50K 10-Q · filed 2012-08-09 | $144.00K 10-Q · filed 2012-08-09 | |||
| 2011-09-30 | $62.50K 10-Q · filed 2012-11-06 | $125.00K derived: sum of 2 quarters · filed 2012-11-06 | $125.00K 10-Q · filed 2012-11-06 | ||
| 2011-06-30 | $62.50K 10-Q · filed 2012-08-09 | $62.50K 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |